Regression of myocardial cellular hypertrophy with vasodilator therapy in chronic congestive heart failure associated with idiopathic dilated cardiomyopathy
- 1 May 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 51 (8) , 1392-1398
- https://doi.org/10.1016/0002-9149(83)90318-1
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Acute and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance.Circulation, 1981
- Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.Circulation, 1981
- Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.Circulation, 1981
- Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure.Heart, 1980
- Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators.Circulation, 1980
- Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failureThe American Journal of Cardiology, 1979
- Immediate effects of hydralazine-isosorbide dinitrate combination on exercise capacity and exercise hemodynamics in patients with left ventricular failure.Circulation, 1979
- Long-term outpatient vasodilator therapy of congestive heart failureThe American Journal of Medicine, 1978
- Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failurePublished by Elsevier ,1977
- Vasodilator Therapy — A Physiologic Approach to the Treatment of Heart FailureNew England Journal of Medicine, 1977